المؤلفون: Laura Y Kummer, Sofie Keijzer, Erik H Vogelzang, Gertjan Wolbink, Laura Boekel, Luuk Wieske, Filip Eftimov, Maurice Steenhuis, Michael T Nurmohamed, Ronald van Vollenhoven, Gestur Vidarsson, T. Rispens, Koos P J van Dam, Joep Killestein, Olvi Cristianawati, S. Marieke van Ham, Zoé L.E. van Kempen, Yaëlle R Besten, Eileen W Stalman, Sander W. Tas, Alexandre E Voskuyl, Taco W. Kuijpers, Femke Hooijberg, Maarten Boers

المساهمون: SILS Other Research (FNWI), Rheumatology, AII - Inflammatory diseases, APH - Societal Participation & Health, Neurology, Amsterdam Neuroscience - Neuroinfection & -inflammation, Medical Microbiology and Infection Prevention, AII - Infectious diseases, Epidemiology and Data Science, APH - Methodology, ACS - Atherosclerosis & ischemic syndromes, Graduate School, Landsteiner Laboratory, ANS - Neuroinfection & -inflammation, Clinical Immunology and Rheumatology, AMS - Musculoskeletal Health, Paediatric Infectious Diseases / Rheumatology / Immunology, ARD - Amsterdam Reproduction and Development, Experimental Immunology, EURO-NMD

المصدر: Boekel, L, Steenhuis, M, Hooijberg, F, Besten, Y R, van Kempen, Z L E, Kummer, L Y, van Dam, K P J, Stalman, E W, Vogelzang, E H, Cristianawati, O, Keijzer, S, Vidarsson, G, Voskuyl, A E, Wieske, L, Eftimov, F, van Vollenhoven, R, Kuijpers, T W, van Ham, S M, Tas, S W, Killestein, J, Boers, M, Nurmohamed, M T, Rispens, T & Wolbink, G 2021, ' Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands : a substudy of data from two prospective cohort studies ', The Lancet Rheumatology, vol. 3, no. 11, pp. e778-e788 . https://doi.org/10.1016/S2665-9913(21)00222-8, https://doi.org/10.1016/S2665-9913(21)00222-8
The Lancet. Rheumatology, 3(11), e778-e788. Elsevier Ltd
The Lancet. Rheumatology
The Lancet Rheumatology, 3(11), e778-e788. Lancet Publishing Group

مصطلحات موضوعية: medicine.medical_specialty, biology, business.industry, Multiple sclerosis, Immunogenicity, Immunology, Odds ratio, Articles, medicine.disease, Vaccination, Rheumatology, Internal medicine, medicine, biology.protein, Immunology and Allergy, Dosing, Antibody, Seroconversion, Prospective cohort study, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5058ec41cc875d2674bd64b83a76a66b
https://dare.uva.nl/personal/pure/en/publications/antibody-development-after-covid19-vaccination-in-patients-with-autoimmune-diseases-in-the-netherlands(036a10d7-30ae-4847-93fc-d95a956d1c63).html